Why EUDAMED Is Becoming Mandatory
The European Commission has confirmed that EUDAMED will become fully mandatory from 28 May 2026 for medical device and IVD manufacturers operating under MDR (EU) 2017/745 and IVDR (EU) 2017/746.
EUDAMED is designed to improve transparency, traceability, and regulatory oversight across the EU medical device market. Once mandatory, it will serve as the central regulatory database for:
- Economic operator registration
- UDI and device registration
- Certificates issued by Notified Bodies
- Market surveillance coordination
For manufacturers, this means EUDAMED registration is no longer optional or phased. It becomes a legal obligation.
What Changes on 28 May 2026
From this date:
- Actor registration becomes mandatory
- UDI and device registration must be completed before market placement
- Certificates must be uploaded into EUDAMED
- Authorities will rely on EUDAMED data for surveillance
National databases will gradually be replaced by centralized EUDAMED processes.
For companies placing devices on the EU market, this marks a structural shift in compliance operations.
The Four Mandatory EUDAMED Modules
1. Actor Registration (SRN Requirement)
Manufacturers, Authorized Representatives, and Importers must:
- Register in EUDAMED
- Obtain a Single Registration Number (SRN)
- Maintain updated economic operator data
Without a valid SRN, device registration cannot proceed.
2. UDI and Device Registration Module
All devices placed on the EU market must be entered into the UDI module.
This includes:
- Basic UDI-DI
- Device identifiers
- Risk classification
- Intended purpose
- Market status
Legacy devices must also be registered within transitional deadlines.
3. Notified Body & Certificates Module
Notified Bodies must upload:
- MDR and IVDR certificates
- Suspensions or withdrawals
- Scope information
Manufacturers must ensure certificate data matches internal documentation and labeling.
4. Market Surveillance Module
This module supports:
- Competent authority coordination
- Safety signal tracking
- Enforcement actions
Accurate data submission reduces compliance risk during inspections.
Key EUDAMED Deadlines Manufacturers Must Track
| Deadline | Obligation |
| 28 May 2026 | Mandatory use of core EUDAMED modules |
| 28 November 2026 | Deadline to register legacy devices |
| 28 May 2027 | Completion of certificate uploads issued before 2026 |
*Missing these deadlines may delay market access or trigger regulatory findings.
Impact on MDR and IVDR Compliance Strategy
EUDAMED compliance is not just an administrative update.
It directly affects:
- Technical documentation alignment
- UDI strategy
- Labeling consistency
- Post-market surveillance reporting
- Vigilance coordination
Manufacturers must integrate EUDAMED obligations into their Quality Management System.
Step-by-Step Preparation Plan for Manufacturers
Step 1: Verify Actor Registration Status
Ensure SRN has been issued and validated.
Step 2: Audit Device Portfolio
Identify all devices requiring UDI and EUDAMED registration.
Step 3: Align UDI Data with Technical Documentation
Check consistency between IFU, labeling, and EUDAMED entries.
Step 4: Update QMS Procedures
Add EUDAMED data governance controls.
Step 5: Conduct Internal Mock Submission
Test internal workflows before the mandatory deadline.
Common EUDAMED Compliance Mistakes to Avoid
- Delaying SRN registration
- Inconsistent UDI data
- Poor documentation traceability
- Not updating legacy device data
- Treating EUDAMED as a one-time upload
EUDAMED requires ongoing data maintenance, not one-time submission.
How Maven Supports EUDAMED Compliance
Maven assists manufacturers with:
- Actor registration and SRN application support
- UDI strategy planning and documentation alignment
- Technical documentation review
- CE certification coordination
- Post Market Surveillance integration
- Regulatory gap analysis for MDR and IVDR
Final Thoughts
The EUDAMED mandatory deadline of 28 May 2026 represents one of the most significant regulatory shifts under MDR and IVDR.
Manufacturers who begin preparation early will reduce compliance risk, avoid data inconsistencies, and strengthen EU market access continuity.
EUDAMED is no longer a future system. It is becoming the backbone of EU medical device regulation.
